EUCTR2004-001287-49-IT进行中（未招募）不适用
52-week, open, randomized, multinational, multicenter clinical trial comparing insulin glulisine in combination with insulin glargine in an intensified insulin regimen to a two-injection conventional insulin regimen in type 2 diabetes mellitus patients with poor glycemic control pretreated with a two-injection conventional insulin therapy
AVENTIS PHARMA S.P.A.0 个研究点目标入组 372 人开始时间: 2007年2月7日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 372
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
52-week, open, randomized, multinational, multicenter clinical trial comparing insulin glulisine in combination with insulin glargine in an intensified insulin regimen to a two-injection conventional insulin regimen in type 2 diabetes mellitus patients with poor glycemic control pretreated with a two-injection conventional insulin therapy. - GINGER-StudyEUCTR2004-001287-49-ESAventis Pharma Deutschland GmbH372
进行中（未招募）
1 期
52-week, open, randomized, multinational, multicenter clinical trial comparing insulin glulisine in combination with insulin glargine in an intensified insulin regimen to a two-injection conventional insulin regimen in type 2 diabetes mellitus patients with poor glycemic control pretreated with a two-injection conventional insulin therapy - GINGER-StudyDiabetes mellitus type 2Classification code 10012613EUCTR2004-001287-49-SKSanofi Aventis Deutschland GmbH372
进行中（未招募）
1 期
52-week, open, randomized, multinational, multicenter clinical trial comparing insulin glulisine in combination with insulin glargine in an intensified insulin regimen to a two-injection conventional insulin regimen in type 2 diabetes mellitus patients with poor glycemic control pretreated with a two-injection conventional insulin therapy - GINGER-StudyDiabetes mellitus type 2Classification code 10012613EUCTR2004-001287-49-GBSanofi-Aventis Deutschland GmbH268
进行中（未招募）
不适用
52-week, open, randomized, multinational, multicenter clinical trial comparing insulin glulisine in combination with insulin glargine in an intensified insulin regimen to a two-injection conventional insulin regimen in type 2 diabetes mellitus patients with poor glycemic control pretreated with a two-injection conventional insulin therapy - GINGER-StudyDiabetes mellitus type 2Classification code 10012613EUCTR2004-001287-49-SESanofi-Aventis Deutschland GmbH268
已完成
不适用
Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes-E669 Obesity, unspecifiedObesity, unspecifiedE669PER-053-08sanofi-aventis Recherche & Development,